Pharma AI adoption fails not because of the technology — but because organizations deploy tools before they're ready to use them.
Mark Talens
Advertisement
Articles by Mark Talens
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs
2
Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech
3
What Supply Chain Resilience Actually Requires in a Volatile Global Market: LogiPharma2026
4
FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer
5